CASSAVA SCIENCES INC Logo

CASSAVA SCIENCES INC

Clinical-stage biotech developing treatments for Central Nervous System disorders.

SAVA | US

Overview

Corporate Details

ISIN(s):
US69562K5065 (+1 more)
LEI:
Country:
United States of America
Address:
6801 N CAPITAL OF TEXAS HIGHWAY, 78731 AUSTIN

Description

Cassava Sciences, Inc. is a clinical-stage biotechnology company that develops investigational treatments for Central Nervous System (CNS) disorders. The company's primary focus is on its lead drug candidate, simufilam, a proprietary oral small molecule. Simufilam is designed to modulate the activity of the filamin A (FLNA) protein, which is involved in regulating neuronal development. The development program for simufilam targets conditions such as tuberous sclerosis complex (TSC)-related epilepsy and other mTOR pathway disorders. Preclinical studies in TSC models have shown that simufilam may reduce seizure frequency, supporting plans for future clinical trials.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-08-08 14:13
FORM 8-K
English ZIP 113.2 KB
2024-07-22 14:12
FORM 8-K
English ZIP 96.4 KB
2024-07-18 14:14
FORM 8-K
English ZIP 137.7 KB
2024-07-17 15:15
FORM 8-K
English ZIP 100.9 KB
2024-07-01 14:00 English ZIP 109.4 KB
2024-05-22 22:58
FORM 8-K
English ZIP 82.7 KB
2024-05-22 22:54
FORM 4
English ZIP 6.8 KB
2024-05-22 22:53
FORM 4
English ZIP 6.8 KB
2024-05-22 22:52
FORM 4
English ZIP 6.9 KB
2024-05-22 22:51
FORM 4
English ZIP 6.8 KB
2024-05-17 01:13
FORM 4
English ZIP 6.7 KB
2024-05-13 22:30
FORM 8-K
English ZIP 76.3 KB
2024-05-13 22:19
FORM 4
English ZIP 6.9 KB
2024-05-13 22:19
FORM 4
English ZIP 6.9 KB
2024-05-13 22:17
FORM 4
English ZIP 7.0 KB

Automate Your Workflow. Get a real-time feed of all CASSAVA SCIENCES INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CASSAVA SCIENCES INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CASSAVA SCIENCES INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Evotec SE Logo
A life science company offering drug discovery and development partnership solutions.
Germany
EVT
EXICURE, INC. Logo
Early-stage biotech developing nucleic acid therapies based on SNA technology.
United States of America
XCUR
EyeGene,Inc Logo
Develops gene/cell therapies for age-related diseases and preventive vaccines.
South Korea
185490
Femtobiomed Inc. Logo
Develops a non-viral intracellular delivery platform for cell and gene therapy.
South Korea
327610
Develops AI data center campuses with co-located hybrid power generation.
United States of America
FRMI
Fluicell AB Logo
A biotech firm creating engineered tissues for regenerative medicine and drug development.
Sweden
FLUI
Foghorn Therapeutics Inc. Logo
Develops medicines targeting the chromatin regulatory system for oncology.
United States of America
FHTX
Fortrea Holdings Inc. Logo
A global CRO providing clinical development and patient access solutions to life sciences.
United States of America
FTRE
FUSION ANTIBODIES PLC Logo
CRO providing end-to-end services for preclinical antibody development.
United Kingdom
FAB
Genenta Science S.p.A. Logo
Clinical-stage developer of hematopoietic stem cell gene therapies for immuno-oncology.
United States of America
GNTA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.